Medtech firms clash over reverse shoulder surgery tech

US medical device company alleges Catalyst Orthoscience infringed patent through reverse shoulder surgery system | Firm seeks to enforce a patent granted in October last year.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Medtech firm faces lawsuit over COVID–19 design

2 August 2022 Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Americas

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Medtech firms clash over reverse shoulder surgery tech

More on this story

Editor's picks

Editor's picks

More features